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The  capillary tube  technique  for  assaying  macrophage  migration  (1)  has  been 
widely used in studies on cellular immunity and has allowed a  better understanding 
of  lymphocyte-macrophage interaction  associated  with  the  expression  of  delayed 
hypersensitivity. The sensitive lymphocyte on exposure to specific antigen (2,  3) has 
been shown to produce a  soluble effector molecule called migration inhibitory factor 
(MIF),  1 which  has  been  characterized as  an  acidic glycoprotein with  a  molecular 
weight of 35,000-55,000  (4,  5).  MIF inhibits the migration of the peritoneal macro- 
phage, and recent evidence suggests that its primary biological function may be to 
activate macrophages (6). The mechanism of these actions is not understood. 
Understanding  of the  mode  of  action of  a  variety of effector molecules on 
their respective target cells has been advanced in recent years by recognition 
of the existence of specific receptors on cell surfaces. The application of basic 
receptor  principles  to  the  effector  molecules  involved  in  the  expression  of 
cellular  immunity  appeared  to  us  appropriate.  Experiments  utilizing  pulse 
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exposure of guinea pig macrophages to MIF-containing supernatants provided 
evidence for a  dose,  time,  and temperature-dependent  adsorption of MIF  to 
the peritoneal  macrophage.  By  contrast,  adsorption of  MIF  to  the  alveolar 
macrophage was not observed.  The  interaction  of  MIF  with  the  peritoneal 
but not the alveolar macrophage argues for selectivity of 13qnphocyte modula- 
tion of macrophage populations mediated by specific  receptors. 
Materials and Methods 
Sensitization.--Harfley strain guinea pigs weighing 300-400 g were used  throughout this 
study.  Each animal was  sensitized by intradermal injection into  the four footpads with a 
total of 0.2 ml of an emulsion containing 0.5 mg of bovine gamma globulin (BGG), crystalline, 
Cohn fraction II,  (Armour Pharmaceutical Co.,  Kankakee,  Ill.),  and 0.5 mg of heat-killed 
tubercle bacilli (strain H37Rv)  incorporated in Freund's complete adjuvant (Difco Labora- 
tories, Inc., Detroit, Mich.). 
Cell Collection.--Peritoneal  exudate  cells  (P.M.)  used  for  assay  of  MIF  activity  were 
collected from normal nonsensitized guinea pigs 72  hr after the intraperitoneal injection of 
30 ml of sterile light paraffin oil (Fisher Scientific Company, Fairlawn, N. J.). Animals were 
sacrificed by cardiac bleeding and cervical dislocation.  Exudate  cells were collected in  120 
ml of prechilled Hanks'  balanced salt solution containing 5 units heparin/ml (HBSS)  and 
were washed twice in HBSS by centrifugation at 220 g for 5 rain at 4°C. 
Normal  alveolar macrophages  (A.M.)  were  collected  by modification of  the  method  of 
Myrvik (7). To avoid bronchospasm, each donor was injected intraperitoneally with 20 mg of 
Benadryl  (Parke,  Davis and Company,  Detroit,  Mich.)  30 rain before sacrifice. The lungs 
were lavaged with a  total of  120 ml of HBSS,  and the cells obtained were washed twice in 
HBSS by centrifugation at 220 g for 5 rain at 4°C. 
The total yields of cells from peritoneal exudate and lungs averaged 120 X  106 and 50 X 
l06, respectively. The macrophage content from exudates and lungs averaged 70  and 95%, 
respectively. Cell preparations contaminated with erythrocytes were discarded. 
Production of MIF by Lymph Node Lymphocyte  C~dture.--MIF-eontaining  supernatants 
were produced by modification of the method of Bloom and Bennett (8).  The axillary, sub- 
clavian, femoral, and popliteal lymph nodes were removed from guinea pigs 14-16 days after 
BGG sensitization, and  the nodes were  teased  apart in Eagle's minimal essential medium 
(Grand Island Biological  Co.,  Grand Island,  N.Y.)  containing penicillin  100 units/ml and 
streptomycin 100 #g/ml (MEM). The cell suspension was filtered through a No.  100 stainless 
steel mesh screen,  the remaining lymph node fragments were washed once with additional 
MEM,  and  the washing fluid was  added  to  the initial cell  suspension after filtration. The 
cells were washed twice in MEM and counted. Approximately 500 )<  106 cells were obtained 
from each animal of which more than 85% appeared to be lymphocytes. The cells were sus- 
pended in serum-free MEM containing L-glutamine (2 m~i/liter) and cultured at a  concen- 
tration of  15  ;<  106/ml and density of 4-5  X  106 cm  2 in  Falcon T  flasks  (Falcon Plastics, 
Los Angeles, Calif.). BGG was added to half the flasks at a final concentration of 1 mg/ml, 
and the flasks were incubated for 24 hr at 37°C in ~ CO,2 incubator. Control and active super- 
natants were  then pooled separately and centrifuged first at 220 g for  10 min and then at 
3000 g for  10 min at 4°C  to remove cells  and debris. The control supernatant was reconsti- 
tuted with BGG at a final concentration of 1 mg/ml. Both the reconstituted control (C) and 
the preincubated active  (A)  supernatants were  sterilized by  Millipore filtration  (0.45  m/~) 
(Millipore Corp., Bedford, Mass.), divided into 1.5-ml aliquots, and stored at -70°C. Before 
in vitro assay the supernatants were supplemented with 15% decomplemented normal guinea 
pig serum  (Grand Island Biological Co.).  Dilutions of supernatants were  made with MEM 
containing 15% guinea pig serum (MEM-S). 
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in 1-ml aliquots to 12  X  75 mm plastic disposable test tubes (Falcon Plastics). After centrif- 
ugation, the supernatants were discarded, and the cells resuspended  in 0.2  ml of  an appro- 
priate dilution of control or active supernatant. Two capillary tubes (1.3-1.5  X  75 mm OD) 
were ill,  led with the suspension from each tube and plugged with clay (Seal-ease, Clay-Adams 
Inc.,  New  York).  After centrifugation at 90 g  for  5  min,  each capillary tube was  cut just 
below the cell fluid interface. Duplicate capillary tubes were mounted by means of silicone 
grease in a  small tissue culture chamber which was filled with the corresponding dilution of 
control or active supernatant and sealed with a cover slip. The chambers were constructed by 
attaching small glass rings (18 X  5 ram) to a glass plate with epoxy glue. After incubation in 
moist chambers for 18 hr at 37°C, the areas of migration were magnified by a microprojector 
(Bausch and Lomb, Inc., Rochester, N.Y.), traced, and measured by planimetrv. The results 
were expressed as 
Per cent inhibition =  I00 --  mean area of migration in A supernatant/ 
mean area of migration in C supernatant X  100. 
The results of each series of experiments were expressed as the mean with its standard error 
(SE~). 
Pulse Exposure Technique.--Small plastic  tubes,  each  containing  12  X  l0 t  peritoneal 
cells,  were prepared  as  described above except  that the cells were suspended  in  1.5  ml of 
appropriate dilutions of control or active supernatant containing 15°/o guinea pig serum. The 
tubes were rocked  on a  tilting mixer  (Labindustries, Berkeley,  Calif.)  for  15  min at room 
temperature (25°C). After pulse exposure,  the cells were sedimented by centrifugation, and 
the supernatants removed. In some experiments these were assayed for residual MIF activity 
by the standard migration technique. Pulsed cells were prepared for assay by suspension in 
0.2 ml of MEM-S and transferred to duplicate capillary tubes. Each chamber was filled with 
MEM-S, and the assay carried out as previously described. 
Macrophage Adsorption of MIF Activity.--Macrophages (15-60  X  10t/tube)  were  sus- 
pended in 1.5 ml of a  1:4 dilution of control or active supernatant and rocked for 30 min at 
room  temperature.  Controls consisted of  C  and A  supernatants incubated without macro- 
phages.  After centrifugation,  the supernatants were  removed and  tested for  residual MIF 
activity by the standard assay. 
For  adsorption  experiments  with  nonviable macrophages  both  alveolar  and  peritoneal 
macrophages were frozen as a dry pellet at --70°C for 72 hr. Cell viability was confirmed to 
be <5% by trypan blue exclusion. 
Enzymatic Treatment of Macrophages.--Peritoneal cells  (12  X  10t/tube) were suspended 
in 1 ml of a  trypsin solution (Grand Island Biological Co.)  at a  final concentration of  1 or 
5  mg  trypsin/ml HBSS.  Cells  suspended  in HBSS  alone provided  the incubation control. 
After incubation for 30 rain in a 37°C water bath with constant shaking, the cells were sedi- 
mented by centrifugation, suspended in 1 ml of HBSS containing 2 mg of lima bean trypsin 
inhibitor  (Nutritional  Biochemicals  Corp.,  Cleveland,  Ohio),  and  washed  three  times  in 
HBSS.  Peritoneal cells were  treated in a  similar way with chymotrypsin,  1 mg/ml  (Sigma 
Chemical Co., St. Louis, Mo.), or neuraminidase, 150 #g/ml (Sigma). Because the appropriate 
enzyme inhibitors were not available, the cells were washed three times in HBSS to remove 
residual enzyme. 
The ability of enzymatically treated cells to respond to MIF was determined by the pulse 
exposure technique. Their ability to adsorb MIF was then tested by the macrophage adsorp- 
tion method described above. 
RESULTS 
Comparison of Peritoneal and Alveolar Macrophage Sensitivity to MIF.--The 
sensitivity  of  normal  peritoneal  or  alveolar  macrophage  populations  to  MIF 
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standard migration  technique. The effect of twofold serial dilution of control 
and  active supernatants  on macrophage migration is  shown in  Fig.  1,  which 
summarizes the results of eight experiments with peritoneal exudate cells  and 
six  experiments  with  alveolar  macrophages.  The  migration  of  peritoneal 
macrophages was markedly inhibited  in  the presence of active supernatants; 
however, the migration of alveolar macrophages was not significantly inhibited 
at any of the dilutions of supernatants tested. The inhibition of peritoneal cell 
migration by MIF-containing supernatant exhibited  a  dose-response relation- 
ship within the range of dilutions tested. Each twofold dilution of supernatant 
resulted in a mean decrease of per cent inhibition of migration of approximately 
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I:IG. 1.  Effect of dilution of MIF-containing supernatants generated from BGG-sensitive 
guinea pig lymph node lymphocytes on the migration of normal peritoneal (P.M., e--O) 
and alveolar (A.M., O--O) macrophages. The response was measured by the standard MIF 
assay with continuous exposure to MIF and is expressed as percentage inhibition of migra- 
tion -4- SEM. 
and the inhibition of migration of these cells (Fig. 1). The data on the abscissa 
were replotted as MIF concentration in arbitrary units so that 1 unit of MIF 
equals  the  least  amount  of detectable  inhibitory  activity  (i.e.  that  amount, 
present in 1.5 ml of a 1 : 64 dilution of supernatant). Fig. 2 shows the relationship 
of  MIF  in  units  to  the  per  cent inhibition  of migration.  MIF,  at  low  con- 
centration,  produced a  progressive  inhibition  of  migration;  however,  as  in- 
hibition  approached  50%,  further  increases  in  MIF  concentration produced 
little  additive  effect.  This  relationship  suggests  that  a  saturation  process  is 
involved.  The  formula  which  describes  this  rectangular  hyperbola  is  y  -- 
ax/b +  x  where y  =  per cent inhibition of migration, x  =  units of MIF, a  = 
maximal percentage inhibition of migration, and b =  number of units of MIF 
to give ~  maximal inhibition. From the formula, MIF in units =  5y/78 --  y, LEU,  EDDLESTON,  I-IADDEN,  AND  GOOD  593 
we were able to estimate the quantity of MIF present in a  given supernatant 
based on a measured inhibition of migration. 
Pulse Exposure of Peritoneal Macrophages to MIF.--In order to investigate 
the early interaction between MIF and its target cells,  normal peritoneal cells 
were exposed for 15  rain  at 25°C  to  active supernatants  and  their migration 
subsequently determined in medium containing no MIF. The results of eight 
pulse exposure experiments are shown in Fig. 3  and are compared with those 
obtained by the standard  assay technique.  The pulse exposure technique pro- 
duced  a  linear  dose-response relationship  parallel  to  that  obtained  with  the 
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FIG. 2.  Relationship of the migration inhibition response  of normal peritoneal macrophages 
and the quantity of MIF expressed  in arbitrary units (1 unit  =  amount of MIF in 1.5 ml of 
a 1:64 dilution of active supernatant derived from the effect of supernatant  dilution on mi- 
gration in the standard assay). 
conditions used, pulse exposure results in an average reduction of the expression 
of MIF units of 50 %, which is independent of MIF concentration. 
Adsorption of MIF Activity  by Peritoneal Macrophages.--The  results of the 
previous  experiments  suggested  that  MIF is  adsorbed  by peritoneal  macro- 
phages  during  exposure  to  active  supernatants.  To  explore  this  possibility, 
selected dilutions of control and active supernatants were incubated with 12 X 
106  peritoneal  macrophages for  15  rain  at 25°C  and  then  tested for residual 
activity by the standard assay. The results of four experiments were analyzed 
to determine the amount of MIF adsorption in units and are shown in Fig. 4. 
MIF units removed by adsorption are plotted against the total number of units 
available in unadsorbed  control  supernatants.  The results  confirm that pulse 
exposure resulted in removal of MIF from active supernatants. This adsorption 
was dose dependent  at low  concentrations  of MIF but  showed saturation  at 594  MACROPHAGE  RECEPTOR  FOR  MIF 
higher concentrations. These results correspond to those obtained for migration 
inhibition (Fig. 2)  and indicate that the observed plateau in migration inhibi- 
tion may result from saturation in binding of MIF. 
Effect of Time,  Temperature, Cell Number,  and Cell Viability  on  Adsorption 
of MIF  to  Peritoneal  Maerophage.--To  determine  the  time-course  of  MIF 
adsorption to peritoneal macrophages, pulse exposures were performed for 2, 
5,  15,  and  30 rain using  a  1:4 dilution of active supernatant.  The cells  were 
assayed as described for pulse exposure, and  the adsorbed supernatants were 
tested for residual  MIF  activity by the standard  assay. The results of three 
such experiments are shown in Fig. 5. Extending the time of exposure of cells 
to  MIF  resulted  in  increasing  cellular adsorption  as  indicated  by increasing 
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FIG.  ,3.  The effect of pulse exposure (e--e)  compared with continuous exposure (©  O) 
of  dilutions of  MIF-containing supernatants  to  inhibit the migration of  peritoneal  macro- 
phages. 
inhibition  of migration of  adsorbing  cells and  declining residual  supernatant 
MIF remaining to inhibit a second population of macrophages. A replot of the 
data on the ordinate in units of MIF would accentuate the rate at which MIF 
is removed from the supernatant. These data indicate that the MIF  adsorption 
during the 30 min period approaches equilibrium  and  a  plateau  of migration 
inhibition  results. 
Results of five experiments on the effect of temperature on MIF binding are 
depicted in Fig. 6. In these experiments temperatures of 4 °, 25  °, and 37°C were 
maintained during the 15 min exposure of peritoneal cells to both active and 
control  supernatants.  Temperature  during  the  pulse  exposure  did  not  sig- 
nificantly affect the  subsequent migration of macrophages exposed to control 
supernatants;  however,  increasing  temperature  is  associated  with  increasing 
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FIG. 4.  The relationship of the units of MIF available and the amount bound by 12  X  106 
peritoneal macrophages during pulse exposure for 15 rain at 25°C. Total MIF available and 
residual MIF after pulse exposure were determined by the standard assay, and MIF bound 
was calculated as the difference between total and residual MIF. 
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FIG.  5.  Effect of time of adsorption on the removal of migration inhibitory activity from 
active supernatants (O--O) and the corresponding increase of migration inhibition of the 
cells used for adsorption (•-- •). 596  MACROPHAGE  RECEPTOR  ~0R MIF 
peratures of 4 °, 25  °, and 37°C on binding corresponds to 1.25, 4.0, and 6.0 units 
of MIF bound, respectively. 
To study the effect of increasing cell numbers on adsorption of MIF activity, 
supernatants  containing  10 units  of MIF  (1:4 dilution)  were exposed to  15, 
30,  or  60  X  106  peritoneal  macrophages  for 30  Inin  at  room  temperature. 
Residual  MIF  supernatant  activity was  determined  by  the  standard  assay. 
The results of five experiments are summarized in Fig. 7. The migration data 
has been translated into MIF units and the MIF units  adsorbed are plotted 
against  cell  number.  Increasing  the number  of peritoneal  cells  progressively 
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FI6. 6.  Effect of temperature during pulse exposure on the ability of normal peritoneal 
macrophages to express  migration inhibition. 
higher cell numbers  as MIF  concentration became limiting. Alveolar macro- 
phages at high concentrations were ineffective in adsorbing MIF. 
To determine the effect of cell viability on the adsorption of MIF to macro- 
phages,  peritoneal  and  alveolar  macrophages  were  rendered  nonviable  by 
freezing. Nonviable macrophages (60)<  106) were exposed to MIF for 45 min 
at 25°C,  the cells sedimented,  and  the supernatants  tested for residual MIF 
activity. The results of three experiments indicated that nonviable peritoneal 
macrophages  adsorbed  80%  of  the  MIF  activity, which  was  equal  to  that 
adsorbed  by viable  cells  under these conditions. Equivalent numbers of non- 
viable alveolar macrophages failed to adsorb MIF. 
Effect of Enzymatic  Treatment of Peritoneal  Macrophages  on  their Ability to 
Respond to and Adsorb MIF.--If adsorption of MIF by peritoneal macrophages LEU~  EDDLESTON,  HADDEN',  AND  GOOD  597 
were due to surface binding of the effector molecule, enzymatic pretreatment 
of these cells might be expected to interfere with their ability both to respond 
to and to adsorb MIF from active supernatants. The effect of pretreatment of 
peritoneal  macrophages  with  trypsin,  chymotrypsin,  and  neuraminidase  on 
their ability to respond to pulse exposure of 1 : 4 dilution of active supernatant 
are shown in Table I. After exposure to trypsin at a  concentration of 1 mg/ml 
for 30 rain at 37°C,  the peritoneal macrophages were significantly impaired in 
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Fro.  7.  Effect of the number of adsorbing alveolar macrophages (A.M., 0--0)  and peri- 
toneal macrophages (P.M., O--O) on the removal of MIF from active supernatants  con- 
taining a total of 10 units of MIF. Pulse adsorption was performed for 30 min at 25°C with 
varying numbers of cells, and the supernatants were retested for MIF activity in the standard 
assay. 
unaffected. Cells treated with 5 mg/ml trypsin were even less responsive. The 
active supernatants which had been exposed to trypsinized cells showed no loss 
of MIF activity, thereby excluding the possibility that the failure of trypsinized 
macrophages to respond  to MIF was due  to destruction  of MIF by residual 
cell-associated  enzyme.  The  results  of  experiments  with  chymotrypsin  (1 
mg/ml) were similar. Neuraminidase (150 ~g/ml) not only failed to reduce the 
ability of peritoneal macrophages to respond  to MIF,  but tended  to increase 
their sensitivity. 
Because trypsin at a concentration of 5 mg/ml was most effective in reducing 
the  response  of  peritoneal  macrophages  to  MIF,  this  concentration  of  the 
enzyme was used to study the ability of enzyme-treated cells to adsorb MIF. 598  MACROPHAGE RECEPTOR FOR  MIF 
Active supernatants were exposed to 30 X  106 trypsinized and control peritoneal 
macrophages for 30 rain at room temperature and subsequently tested for MIF 
in the standard assay. Cells subjected to no enzyme treatment adsorbed 75 % 
of  the  MIF  present  while  trypsinized  cells  adsorbed  none.  The  difference 
between the adsorptive capability of trypsinized versus control cells was highly 
significant (P <  0.001). 
DISCUSSION 
The assay for macrophage migration inhibitory factor (MIF) has been used 
for several years  as  an  in  vitro model of delayed hypersensitivity.  Initially, 
peritoneal  exudates  containing  sensitive lymphocytes and  macrophages were 
incubated  with  antigen  and  the  effect of progressive generation  of  MIF  on 
macrophage inhibition was measured (1). Later,  crude MIF-containing super- 
TABLE  I 
Effect of Enzyme Pretreatment of Peritoneal Macrophages on their Ability to Respond to MIF 
Response to MIF as per cent  No. of  _P value compared  with  Enzyme treatment  inhibition of migration  experiments  control 
Control  37.9  4- 3.7  8 
Trypsin  13.1  4-  6.7  6  P  <  0.01 
(1 mg/ml) 
Trypsin  5.6  4-  12.5  2  P  <  0.01 
(5 mg/ml) 
Chymotrypsin  15.3 4-  13.4  2  P  <  0.01 
(1 ml/ml) 
Neuraminidase  47.6  :k 9.1  2  P  <  0.30 
(150 ug/ml) 
natants generated from sensitive lymphocytes incubated with antigen were used 
to inhibit macrophage migration  (2,  3).  More recently, efforts to purify MIF 
from crude supernatants have yielded more specific preparations, unfortunately, 
of diminished activity resulting from the process of purification (5, 9,  10).  This 
gain in specificity has allowed approaches to physicochemical characterization 
but the diminution in activity has made difficult quantitative correlation with 
in vivo sensitivity. Although  these developments offer the advantage of direct 
study of interaction of preformed MIF with its effector cell,  the characteristics 
of this interaction have not been fully analyzed. 
It has been assumed that migration inhibition has a linear relationship with 
MIF concentration and, therefore, is a direct correlate of the degree of delayed 
hypersensitivity. Our observations on the effect of diluting crude supernatants 
containing  MIF  on  inhibition  of migration  indicate  that  the  dose-response 
relationship  involved  in  MIF  expression  shows  saturation  characteristics. 
These observations indicate that this limitation of the migration system makes LEU,  EDDLESTON, HADDEN, AND  GOOD  599 
impossible  direct  and  quantitative  correlation  of  activity in  the  migration 
inhibition assay with the degree of delayed hypersensitivity. The calculation of 
MIF in  arbitrary units based  on  the equation for a  rectangular hyperbola 
provides  a means of quantitation which should be applicable  to capillary tube 
migration methods used by other workers. 
Several mechanisms have been described to mediate the inhibition of macro- 
phage migration. Our data indicate that MIF as a mediator of delayed hyper- 
sensitivity inhibits the migration of the peritoneal  macrophage  but not  that 
of the alveolar macrophage.  Cytophilic antibody with antigen has been shown 
to inhibit the migration of both the peritoneal (11) and alveolar  (12) macro- 
phage.  Immune serum and antigen also inhibit migration of both  peritoneal 
(13)  and alveolar  (R.  W. Leu, unpublished  data)  macrophage.  Evidence for 
other inhibitory factors which  differ in physical  properties  and antigen de- 
pendence from either MIF, cytophilic  antibody, or immune serum have been 
presented  (14-16) but  they remain unclarified.  Thus,  two or more different 
mechanisms  involving both humoral and cellular immunity act to inhibit the 
migration of peritoneal  macrophage,  while only humoral mechanisms  appear 
to inhibit the migration of aveolar macrophage. 
Crude supernatants prepared from sensitive  lymph node  lymphocytes can 
be expected to contain varying amounts of both MIF and antibody depending 
on the methods of immunization and in vitro culture.  These differential  char- 
acteristics  of alveolar and peritoneal macrophages  should be useful as an alter- 
native to physicochemical  separation for separating MIF from the humoral 
factors. 
The use of crude supernatants is prevalent in work with lymphocyte media- 
tors.  Although purification  techniques  are  available,  their  yields  of  semi- 
purified factors are small. In addition to multiple lymphocyte factors,  known 
and unknown, these  supernatants can be envisioned  to contain a  variety of 
nonspecific metabolites and to show varying degrees of nutrient depletion as a 
result of incubation for 24 hr with metabolically active cells. We approached 
this problem  with the presumption that if a  macrophage  receptor for MIF 
existed, then brief exposure of the macrophage  to an active supernatant should 
concentrate MIF onto the cell and exclude  those factors in medium which 
would not be specifically adsorbed.  One would expect  that any other factors 
which  affect the macrophage might be  bound during pulse  exposure  to  an 
active  supernatant;  these  would  include  macrophage  chemotactic  factor, 
aggregating factor, and activating factor in addition to MIF. We acknowledge 
that  these factors which  have  been  defined  biologically may not  represent 
different biochemical entities. Current evidence suggests that only chemotactic 
factor and MIF are different (17). We observed that pulse exposure for 15 rain 
at 25°C removes more than 1/~ of the MIF activity in the original supernatant. 
On the basis of approximate cell-to-supernatant volume ratios,  this transfer of 
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perature  of pulse  exposure to  30 min  at  37°C,  while  inviting  the  occasional 
complication of cell clumping, increased adsorption of the MIF activity. The 
pulse exposure technique offers, therefore, the advantage of a purification step 
in which  the reduction of MIF  activity' from supernatant is predictable. The 
extent to which other lymphocyte mediators are adsorbed to the macrophage 
is under study. The pulse principle, in addition to offering considerable support 
for the existence of a receptor, provided the experimental means by which such 
a receptor concept could be explored. 
Receptor models have been used for years to explain the actions of a variety' 
of drugs  and hormones. Our approach  to the macrophage was guided by ob- 
servations in a number of tissues that the specificity of action of many hormones 
and mediators lies in specific binding to receptors on their target cell surfaces. 
The ideal approach  to mediator-receptor interaction involves purified, assay- 
able components. The lymphocyte and macrophage provided neither. MIF is 
secreted  in  infinitesimally  small  quantities  and  only  the  biological  assay  of 
migration is available as an indication of interaction of MIF with  the macro- 
phage. With these admitted liabilities we offer the following as evidence for the 
presence of a MIF receptor on the peritoneal macrophage: (a) Both viable and 
nonviable  peritoneal  macrophages  selectively  adsorb  MIF  from  an  active 
superantant.  (by The adsorption has a direct dose-response relationship at low 
concentration of MIF,  shows saturation  characteristics when the quantity of 
MIF  exceeds available  receptor sites,  and  shows  a  plateau  of binding  when 
the number of receptors exceeds available MIF at equilibrium. (c) The adsorp- 
tion is time and temperature dependent. (d) Pretreatment of macrophage with 
proteolytic enzymes removes their  ability to  adsorb  and  to  respond to MIF 
while leaving their abilitv to migrate unaffected. (e) Alveolar macrophages do 
not  remove  MIF  activity,  from  an  active  supernatant  thus  demonstrating 
specificity of the MIF receptor. 
The features of interaction of MIF with  the  peritoneal  macrophage  corre- 
spond remarkably to the interactions described for insulin and the fat cells (18). 
It is of interest that the fat ceil regains its insulin receptors within hours after 
trypsinization  (19).  We  suggest  this  relationship  is  the  explanation  for  the 
observation (20)  that the trypsinized macrophage will  respond to continuous 
exposure to MIF. 
The MIF receptor differs from the macrophage receptor described for anti- 
body in that the latter resists proteolytic digestion (21). Both insulin (18)  and 
cytophilic antibody (21)  bind to their receptors to form dissociable complexes. 
Our preliminary attempts to elute MIF from peritoneal cells by repeated wash- 
ing, heat treatment (56°C for 30 min),  and chelation (5 mM ethylenediamine- 
tetraacetate  for  30 rain)  have been unsuccessful suggesting either that  MIF 
is  bound  with  unusual  avidity to its  receptor or  that  it is  inactivated  after 
initial binding. 
The role of MIF as a participant in immune responses remains unclear. One LEU,  EDDLESTON,  HADDEN, AND  GOOD  601 
questions the biological function of MIF to inhibit migration in the presence of 
a chemotactic factor to attract actively migrating macrophages. Evidence has 
been presented that MIF is indistinguishable  in its physical properties  from a 
factor which activates macrophages  (6). We have shown in preliminary work 
that macrophages pulsed with active supernatants subsequently undergo those 
morphological and adherence changes described by Mooney and Waksman (22) 
thus  indicating  that  macrophage  activation is  a  concomitant of  migration 
inhibition and results from the adsorption of MIF. The inhibition of migration 
may well be secondary to the more important process of activation. Thus, the 
primary biological role of MIF may lie in its action to activate macrophages 
and thereby expand the expression of cellular immunity. 
The role of macrophage  activation in the expression of cellular  immunity 
in vivo has recently been reviewed by Mackaness (23). Lymphocyte-induced 
macrophage activation in  vivo is  associated  with  enhanced phagocytic and 
bactericidal capacities. The study of the activation process in vitro has provided 
evidence that MIF-rich supernatants or semipurified MIF enhance phagocytic 
capability of peritoneal  macrophages  (24) and their bactericidal  capacity (25, 
26). The demonstration that the lymphocyte can be  induced by antigen to 
produce a soluble mediator which activates macrophages  supports a concept of 
immune modulation of macrophage  function which would operate to varying 
degree in all cellular immune responses. 
An important aspect  of this modulation would appear to be its specificity. 
The action of MIF on the peritoneal macrophage indicates that the circulating 
blood monocyte which is the precursor  for the peritoneal  macrophage  is the 
population subject to regulation by the sensitive  lymphocyte through MIF. 
The lack of a receptor for MIF on the alveolar macrophage  suggests that the 
alveolar macrophage functions with a certain autonomy with respect to cellular 
immunity. Recent evidence supports the lack of participation of the alveolar 
macrophage in acquired resistance to pulmonary infection with the facultative 
intracellular pathogens,  bacille  Calmette Gu~rin  and  Listeria  monocytogenes 
(27, 28). Additional data suggest that another fixed macrophage population, the 
Kupffer cells, may not participate in  acquired  resistance  to  the facultative 
pathogen Brucella abortus (29). Further elucidation  of mechanisms of immune 
modulation of various fixed and free macrophage populations represents  an 
important key to understanding local and systemic immunity. 
SUMMARY 
The initial interaction between migration inhibitory factor (MIF)  and the 
guinea pig alveolar  and peritoneal  macrophage  was studied. MIF-containing 
supernatants were generated from sensitized lymph node lymphocytes obtained 
from guinea pigs immunized with bovine gamma globulin in complete Freund's 
adjuvant.  MIF-containing supernatants  were  markedly  inhibitory for  the 
migration of the peritoneal macrophage but had no effect on the alveolar macro- 602  ~ACROPHAGE  RECEPTOR  FOR  MIF 
phage.  A  linear  relationship  was  observed  between  per  cent  inhibition  of 
migration and serial twofold dilution of supernatant.  Reexpressed in arbitrary 
MIF units, this relationship reflects a dose-response relationship with saturation 
characteristics.  Pulse exposure of peritoneal macrophages to MIF resulted in 
adsorption  of  MIF  onto  both  viable  and  nonviable  cells with  corresponding 
depletion of supernatant MIF. The alveolar macrophage did not adsorb MIF. 
Pulse adsorption of MIF onto the peritoneal macrophage is dependent on time, 
temperature, and cell number. Pretreatment of the cells with proteolytic enzyme 
prevents  the  adsorption  of  MIF  while  leaving  migration  unaffected.  These 
observations support the existence of a  specific cell surface receptor for MIF. 
The existence of such a receptor provides selectivity of immune modulation of 
macrophage populations by lymphocytes in delayed hypersensitivity reactions. 
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